Vγ Usage Distinguishes Pro- and Anti-Tumor Intestinal Γδ T Cell Subsets

Bernardo S. Reis,Patrick W. Darcy,Iasha Z. Khan,Olawale Eleso,Caixia Zhu,Marina Schernthanner,Ainsley Lockhart,Aubrey Reed,Juliana Bortolatto,Tiago B. R. Castro,Angelina M. Bilate,Sergei Grivennikov,Daniel Mucida
DOI: https://doi.org/10.1101/2021.11.13.468487
2021-01-01
bioRxiv
Abstract:γδ T cells physiologically scan the intestinal epithelium, representing a substantial fraction of infiltrating lymphocytes in colorectal cancer (CRC), albeit their role in CRC remains unclear. Using murine CRC models, we found that most γδ T cells in pre- or non-tumor colon express Vγ1+ or Vγ7+ and exhibit a cytotoxic profile. Targeting these γδ T cell subsets, as well as conditionally interfering with γδ T cell function at early stages of tumorigenesis led to heightened tumor development, suggesting anti-CRC functions for Vγ1+ and Vγ7+ subsets. In contrast, RORγt+ γδ T cell subsets, including Vγ4+ and microbiotadependent Vγ6+, accumulated during CRC progression. Conditional deletion of RORγt or Vγ chains revealed redundant roles for IL-17–producing Vγ4+ and Vγ6+ γδ T cells in promoting tumor growth. Our results uncover pro- and anti-tumor roles for γδ T cell subsets.
What problem does this paper attempt to address?